Impaired exercise outcomes with significant bronchodilator responsiveness in children with prematurity-associated

Michael Cousins1, Kylie Hart1, E Mark Williams2

  • 1Department of Child Health, Cardiff University School of Medicine, Cardiff, UK.

Insights

Preterm-born children with obstructive lung disease show the most significant exercise capacity issues and benefit most from bronchodilators. These findings can help guide treatment for children with prematurity-associated obstructive lung disease (POLD).

Area of Science:

  • Pediatric Pulmonology
  • Neonatal Health Outcomes
  • Exercise Physiology

Background:

  • Preterm birth interrupts normal lung development, increasing risks for short- and long-term lung disease.
  • Children born preterm, especially those with chronic lung disease of prematurity (CLD), often exhibit spirometry and exercise capacity impairments.
  • Specific lung function phenotypes may differentially impact exercise capacity in this population.

Purpose of the Study:

  • To investigate exercise capacity differences in preterm-born children with specific lung function phenotypes: prematurity-associated obstructive lung disease (POLD) and prematurity-associated preserved ratio of impaired spirometry (pPRISm).
  • To compare exercise capacity in these groups against preterm- and term-born controls with normal lung function.
  • To assess the impact of bronchodilator response on exercise capacity in these distinct groups.

Main Methods:

  • Utilized data from the Respiratory Health Outcomes in Neonates (RHiNO) study, including lung function and cardiorespiratory exercise testing.
  • Included children aged 7-12 years, categorized into POLD (n=18), pPRISm (n=12), preterm-controls (PTc, n=106), and term-controls (T_c, n=66).
  • Administered postexercise bronchodilator testing to evaluate airway reversibility.

Main Results:

  • Children with POLD exhibited reduced relative workload, peak oxygen uptake, carbon dioxide production, and minute ventilation compared to term-controls.
  • POLD children utilized a greater proportion of their breathing reserve than both control groups.
  • POLD children showed the most significant improvement in FEV1 (19.4%) after bronchodilator administration compared to pPRISm, PTc, and Tc groups (p < .001).

Conclusions:

  • Preterm-born children with obstructive airway disease (POLD) experience the greatest exercise capacity impairments.
  • These children also demonstrate a significantly greater positive response to postexercise bronchodilators.
  • Classification into POLD can inform and guide therapeutic strategies for affected children.
Abstract

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
351
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.5K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.0K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.1K
Antiasthma Drugs: &#946;2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
428
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.8K